Concepedia

Pieter Smid

PS

Statistics

Publications

2

Citations

85

H-Index

2

Active since

2003

Affiliations

Solvay (Netherlands)(Current)

Pieter Smid is an author at Solvay (Netherlands) specializing in antipsychotic action, dopaminergic pharmacology, and antipsychotic pharmacology.

Publications per year

2003–2005

2

Publications

2

Synthesis, Structure−Activity Relationships, and Biological Properties of 1-Heteroaryl-4-[ω-(1<i>H</i>-indol-3-yl)alkyl]piperazines, Novel Potential Antipsychotics Combining Potent Dopamine D<sub>2</sub> Receptor Antagonism with Potent Serotonin Reuptake Inhibition

Pieter Smid, Hein K. A. C. Coolen, Hiskias G. Keizer et al. · Journal of Medicinal Chemistry · 2005 · 58 citations · Full text

, , +16

SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition

Rolf van Hes, Pieter Smid, Cees N. J. Stroomer et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 27 citations · Full text

, , +16

1–2 of 2